Skip to main content

Published locations for Two phase 3 trials show benefits of dupilumab for prurigo nodularis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Two phase 3 trials show benefits of dupilumab for prurigo nodularis

User login

  • Reset your password
  • /content/two-phase-3-trials-show-benefits-dupilumab-prurigo-nodularis
  • /clinicianreviews/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab
  • /edermatologynews/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab
  • /familypracticenews/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab
  • /fedprac/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab-prurigo
  • /internalmedicinenews/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab
  • /internalmedicine/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab
  • /dermatology/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab-prurigo
  • /familymedicine/article/262864/medical-dermatology/two-phase-3-trials-show-benefits-dupilumab-prurigo